Patents by Inventor Kenneth R. Hess

Kenneth R. Hess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100009358
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.
    Type: Application
    Filed: December 18, 2008
    Publication date: January 14, 2010
    Applicants: Millennium Pharmaceuticals, Inc., Board of Regents, The University of Texas System
    Inventors: Mark D. Ayers, Jim Stec, Andrew Damokosh, Edwin Clark, Kenneth R. Hess, Gabriel N. Hortobagyi, Lajos Pusztai, W. Fraser Symmans, Robert C. Bast, JR.
  • Patent number: 7504222
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: March 17, 2009
    Assignees: Millennium Pharmaceuticals, Inc., Board of Regents, The University of Texas
    Inventors: Mark D. Ayers, Jim Stec, Andrew Damokosh, Edwin Clark, Kenneth R. Hess, Gabriel N. Hortobagyi, Lajos Pusztai, W. Fraser Symmans, Robert C. Bast, Jr.
  • Publication number: 20030219767
    Abstract: The invention relates to compositions, kits, and methods for detecting, characterizing, preventing, and treating human breast cancers. A variety of newly identified markers are provided, wherein changes in the levels of expression of one or more of the markers is correlated with the presence of breast cancer.
    Type: Application
    Filed: October 31, 2002
    Publication date: November 27, 2003
    Applicants: MILLENNIUM PHARMACEUTICALS, INC., M.D. Anderson Cancer Center
    Inventors: Mark D. Ayers, Jim Stec, Andrew Damokosh, Edwin Clark, Kenneth R. Hess, Gabriel N. Hortobagyi, Lajos Pusztai, W. Fraser Symmans
  • Patent number: 5582703
    Abstract: Phosphor color screens with triad pitches of 150 .mu.m and less are fabricated by a combination of modified microelectronic processing techniques and electrophoretic coating of the phosphors and black screen. Indeed, triad pitches based on 15 .mu.m color line width and 5 .mu.m black matrix between colors are achievable.
    Type: Grant
    Filed: December 12, 1994
    Date of Patent: December 10, 1996
    Assignee: Palomar Technologies Corporation
    Inventors: Esther Sluzky, Santosh K. Kurinec, Kenneth R. Hesse, Luigi Ternullo, Jr.
  • Patent number: 5512210
    Abstract: A far-red emitting phosphor for cathode ray tubes used in liquid crystal light valves comprises Y.sub.3-y Gd.sub.y Al.sub.5-x Ga.sub.x -O.sub.12 :A, where x ranges from 0 to 5, y ranges from 0 to 3, and A is selected from the group consisting of chromium, iron, vanadium, neodymium, dysprostum, cobalt, nickel, titanium or combination thereof.
    Type: Grant
    Filed: December 21, 1993
    Date of Patent: April 30, 1996
    Inventors: Esther Sluzky, Mary A. Lemoine, Kenneth R. Hesse
  • Patent number: 5202777
    Abstract: A far-red emitting phosphor for cathode ray tubes used in liquid crystal light valves comprises Y.sub.3-y Gd.sub.y Al.sub.5-x Ga.sub.x O.sub.12 :A, where x ranges from 0 to 5, y ranges from 0 to 3, and A is selected from the group consisting of chromium, iron, vanadium, neodymium, dysprosium, cobalt, nickel, titanium or combination thereof.
    Type: Grant
    Filed: April 1, 1992
    Date of Patent: April 13, 1993
    Assignee: Hughes Aircraft Company
    Inventors: Esther Sluzky, Mary A. Lemoine, Kenneth R. Hesse
  • Patent number: 5162930
    Abstract: A far-red emitting phosphor for cathode ray tubes used in liquid crystal light valves comprises lithium aluminum (or gallium) oxide, activated with iron or chromium. Increasing the activator concentration from 0.005 mole (commercially available) to about 0.015 to 0.05 mole increases the phosphor efficiency by about 50% and reduces the decay time from 30 msec (for the commerically available material) to 19 msec. Reducing the particle size to an average of 4 .mu.m or less provides the requisite high resolution for the CRT application.
    Type: Grant
    Filed: January 6, 1992
    Date of Patent: November 10, 1992
    Assignee: Hughes Aircraft Company
    Inventors: Esther Sluzky, Mary A. Lemoine, Kenneth R. Hesse
  • Patent number: 5140449
    Abstract: A doubly activated yttriuim aluminum garnet (YAG) phosphor, activated with both europium and chromium, is provided. The concentration of Eu ranges from about 1 to 5 at %, while the concentration of Cr ranges from about 0.1 to 1 at %. The YAG:Eu,Cr phosphor has a line spectrum which more closely matches the spectral sensitivity of amorphous silicon liquid crystal light valves thereby, providing more efficient use of the available energy.
    Type: Grant
    Filed: January 30, 1992
    Date of Patent: August 18, 1992
    Assignee: Hughes Aircraft Company
    Inventors: Esther Sluzky, Mary A. Lemoine, Kenneth R. Hesse
  • Patent number: D985777
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: May 9, 2023
    Inventor: Kenneth R. Hess